The Novel BCR-ABL and FLT3 Inhibitor Ponatinib Is a Potent Inhibitor of the MDR-Associated ATP-Binding Cassette Transporter ABCG2

Rupashree Sen, Maria R. Baer, Jasjeet Bhullar et al.|Molecular Cancer Therapeutics|2012

Cited by 91